批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2016/06/09 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/09/26 |
SUPPL-20(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/08/21 |
SUPPL-21(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/06/04 |
SUPPL-19(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2014/03/28 |
SUPPL-18(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/07/20 |
SUPPL-14(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/09/14 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
N/A
|
|
|
2007/08/10 |
SUPPL-12(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2006/01/19 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/11/24 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/10/15 |
SUPPL-4(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2002/11/15 |
SUPPL-1(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
2001/12/13 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:PIMECROLIMUS 剂型/给药途径:CREAM;TOPICAL 规格:1% 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
021302 |
001 |
NDA |
ELIDEL |
PIMECROLIMUS |
CREAM;TOPICAL |
1% |
Prescription |
Yes |
Yes |
AB |
2001/12/13
|
BAUSCH |
209345 |
001 |
ANDA |
PIMECROLIMUS |
PIMECROLIMUS |
CREAM;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2018/12/27
|
ACTAVIS LABS UT INC |
211769 |
001 |
ANDA |
PIMECROLIMUS |
PIMECROLIMUS |
CREAM;TOPICAL |
1% |
Prescription |
No |
No |
AB |
2019/08/29
|
GLENMARK PHARMS LTD |